Homologous recombination deficiency predicts the response to platinum-based neoadjuvant chemotherapy in early-stage triple-negative breast cancer patients: a systematic review and meta-analysis

BACKGROUND: Recent studies have shown that homologous recombination deficiency (HRD) may be correlated with the pathological complete response (pCR) rate. This meta-analysis aimed to determine the predictive value of HRD for the pCR rate in patients with triple-negative breast cancer (TNBC) receivin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Liulu, Chen, Yuanqi, Cheng, Min-Yi, Zhuang, Xiaosheng, Zou, Jiachen, Wei, Dannuo, Lin, Ying-Yi, Zhang, Yi, Wang, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082757/
https://www.ncbi.nlm.nih.gov/pubmed/35547093
http://dx.doi.org/10.1177/17588359221096253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082757/
https://www.ncbi.nlm.nih.gov/pubmed/35547093
http://dx.doi.org/10.1177/17588359221096253

Ejemplares similares